Orchard Therapeutics PLC - Delisted Stock
Orchard Therapeutics PLC is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Orchard Therapeutics was actively traded.
Valuation
Financial Report 20th of May 2024
Orchard Therapeutics PLC Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Orchard Therapeutics market risk premium is the additional return an investor will receive from holding Orchard Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Orchard Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Orchard Therapeutics' alpha and beta are two of the key measurements used to evaluate Orchard Therapeutics' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.1588 | |||
| Standard Deviation | 0.2558 | |||
| Variance | 0.0654 | |||
| Downside Variance | 0.0256 |
Orchard Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Orchard Therapeutics stock to make a market-neutral strategy. Peer analysis of Orchard Therapeutics could also be used in its relative valuation, which is a method of valuing Orchard Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Orchard Therapeutics Corporate Management
Elected by the shareholders, the Orchard Therapeutics' board of directors comprises two types of representatives: Orchard Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Orchard. The board's role is to monitor Orchard Therapeutics' management team and ensure that shareholders' interests are well served. Orchard Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Orchard Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Fulvio Mavilio | Chief Officer | Profile | |
| Frank Thomas | Pres COO | Profile | |
| Bobby MD | Member CEO | Profile | |
| Benjamin Navon | Director Communications | Profile | |
| John Cerio | Chief Officer | Profile | |
| Braden Parker | Chief Officer | Profile | |
| Nicoletta Loggia | Chief Officer | Profile |
Still Interested in Orchard Therapeutics PLC?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Orchard Stock
If you are still planning to invest in Orchard Therapeutics PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Orchard Therapeutics' history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |